146 related articles for article (PubMed ID: 11109415)
1. [Acute pancreatitis--adverse effect of 5-aminosalicylic acid (mesalazine) in various galenic dosage forms].
Schwörer H; Ramadori G
Dtsch Med Wochenschr; 2000 Nov; 125(44):1328-30. PubMed ID: 11109415
[TBL] [Abstract][Full Text] [Related]
2. [Mesalazine and sulphasalazine for Crohn's disease: few indications, severe adverse reactions].
Uittenbogaart SB; Klemt-Kropp M
Ned Tijdschr Geneeskd; 2011; 155(48):A3842. PubMed ID: 22152414
[TBL] [Abstract][Full Text] [Related]
3. [Pancreatitis associated with 5-aminosalicylic acid].
Eckardt VF; Kanzler G; Rieder H; Ewe K
Dtsch Med Wochenschr; 1991 Apr; 116(14):540-2. PubMed ID: 1707359
[TBL] [Abstract][Full Text] [Related]
4. [Pancreatitis in a patient with Crohn disease treated with mesalazine and azathioprine].
Glintborg B
Ugeskr Laeger; 2000 Aug; 162(34):4553-4. PubMed ID: 10981226
[TBL] [Abstract][Full Text] [Related]
5. Clinical onset of the Crohn's disease after eradication therapy of Helicobacter pylori infection. Does Helicobacter pylori infection interact with natural history of inflammatory bowel diseases?
Jovanovic IR; Milosavjevic TN; Jankovic GP; Micev MM; Dugalic PD; Saranovic D; Ugljesic MM; Popovic DV; Bulajic MM
Med Sci Monit; 2001; 7(1):137-41. PubMed ID: 11208510
[TBL] [Abstract][Full Text] [Related]
6. [Acute pancreatitis induced by drugs derived from 5-aminosalicylic acid: case report and review of the literature].
Decocq G; Gras-Champel V; Vrolant-Mille C; Delcenserie R; Sauvé L; Masson H; Andréjak M
Therapie; 1999; 54(1):41-8. PubMed ID: 10216421
[TBL] [Abstract][Full Text] [Related]
7. [A case of acute pancreatitis caused by 5-aminosalicylic acid suppositories in a patient with ulcerative colitis].
Kim KH; Kim TN; Jang BI
Korean J Gastroenterol; 2007 Dec; 50(6):379-83. PubMed ID: 18159175
[TBL] [Abstract][Full Text] [Related]
8. Mesalazine-associated tubulo-interstitial nephritis in inflammatory bowel disease.
Calviño J; Romero R; Pintos E; Losada E; Novoa D; Güimil D; Mardaras J; Sanchez-Guisande D
Clin Nephrol; 1998 Apr; 49(4):265-7. PubMed ID: 9582560
[TBL] [Abstract][Full Text] [Related]
9. [Eosinophilic pneumonia caused by mesalazine. Report of one case].
Pérez C; Errázuriz I; Brockmann P; González S; Cofré C
Rev Med Chil; 2003 Jan; 131(1):81-4. PubMed ID: 12643224
[TBL] [Abstract][Full Text] [Related]
10. Mesalazine foam (Salofalk foam) in the treatment of active distal ulcerative colitis. A comparative trial vs Salofalk enema. The SAF-3 study group.
Ardizzone S; Doldo P; Ranzi T; Sturniolo GC; Giglio LA; Annese V; D'Arienzo A; Gaia E; Gullini S; Riegler G; Valentini M; Massa P; Del Piano M; Rossini F; Guidetti CS; Pera A; Greinwald R; Bianchi Porro G
Ital J Gastroenterol Hepatol; 1999 Nov; 31(8):677-84. PubMed ID: 10730559
[TBL] [Abstract][Full Text] [Related]
11. Acute pancreatitis after long-term 5-aminosalicylic acid therapy.
Fernández J; Sala M; Panés J; Feu F; Navarro S; Terés J
Am J Gastroenterol; 1997 Dec; 92(12):2302-3. PubMed ID: 9399776
[TBL] [Abstract][Full Text] [Related]
12. A controlled trial comparing ciprofloxacin with mesalazine for the treatment of active Crohn's disease. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID).
Colombel JF; Lémann M; Cassagnou M; Bouhnik Y; Duclos B; Dupas JL; Notteghem B; Mary JY
Am J Gastroenterol; 1999 Mar; 94(3):674-8. PubMed ID: 10086650
[TBL] [Abstract][Full Text] [Related]
13. [Acute renal failure associated with 5-aminosalicylic acid in inflammatory bowel disease].
García-Díaz M; Nevado L; Berenguer A; Bureo JC; Bureo P; Sáenz de Santamaría J
Gastroenterol Hepatol; 1995 Jan; 18(1):18-21. PubMed ID: 7621266
[TBL] [Abstract][Full Text] [Related]
14. [Interstitial pneumonia related to mesalamine].
Lamsiah T; Moudden K; Baaj M; Hadri L
Gastroenterol Clin Biol; 2010 Mar; 34(3):224-6. PubMed ID: 20299168
[TBL] [Abstract][Full Text] [Related]
15. Mesalazine with or without cholestyramine in the treatment of microscopic colitis: randomized controlled trial.
Calabrese C; Fabbri A; Areni A; Zahlane D; Scialpi C; Di Febo G
J Gastroenterol Hepatol; 2007 Jun; 22(6):809-14. PubMed ID: 17565633
[TBL] [Abstract][Full Text] [Related]
16. [Angioedema in Crohn's disease possibly due to mesalazine].
Nguyen-Khac E; Le Baron F; Thevenot T; Tiry-Lescut C; Tiry F
Gastroenterol Clin Biol; 2002 May; 26(5):535-6. PubMed ID: 12122371
[No Abstract] [Full Text] [Related]
17. Crohn's Disease with Mesalazine Allergy that Was Difficult to Differentiate from Comorbid Ulcerative Colitis.
Tsuboi R; Matsumoto S; Miyatani H; Mashima H
Intern Med; 2019 Mar; 58(5):649-654. PubMed ID: 30333413
[TBL] [Abstract][Full Text] [Related]
18. Budesonide and mesalazine in active Crohn's disease: a comparison of the effects on quality of life.
Thomsen OO; Cortot A; Jewell D; Wright JP; Winter T; Veloso FT; Vatn M; Persson T; Pettersson E;
Am J Gastroenterol; 2002 Mar; 97(3):649-53. PubMed ID: 11922560
[TBL] [Abstract][Full Text] [Related]
19. Mesalazine-induced lupus.
Timsit MA; Anglicheau D; Lioté F; Marteau P; Dryll A
Rev Rhum Engl Ed; 1997 Oct; 64(10):586-8. PubMed ID: 9385697
[TBL] [Abstract][Full Text] [Related]
20. [Left-sided hydronephrosis as the first sign of Crohn disease].
Netzer P; Hammer B
Dtsch Med Wochenschr; 1996 May; 121(18):583-7. PubMed ID: 8625785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
